XML 58 R25.htm IDEA: XBRL DOCUMENT v3.23.1
8. Equity Incentive Plan – Stock-Based Compensation Expense and Common Stock Warrants (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Award Activity

A summary of the stock option activity for the year ended December 31, 2022 is as follows:

 

  

Number of

Stock

Options

  

Weighted-

Average Exercise Price

  

Weighted-

Average

Remaining

Contractual Life

  

Aggregate

Intrinsic

Value

 
Outstanding as of December 31, 2021   926,379   $2.08    6.47   $2,856 
Granted   724,937   $2.42    -   $- 
Exercised   (160,212)  $0.26    -   $- 
Forfeited   (91,852)  $3.03    -   $- 
Expired   -   $-    -   $- 
Outstanding as of December 31, 2022   1,399,252   $2.40    7.79   $928 
Exercisable as of December 31, 2022   662,909   $1.79    5.87   $823 
Vested and expected to vest as of December 31, 2022   1,399,252   $2.40    7.79   $928 
Schedule of Ranges of Stock Options

The following table summarizes the outstanding and exercisable options as of December 31, 2022:

 

 

    Options Outstanding     Options Exercisable  
Range of
Exercise Prices
    Number of
Shares
    Weighted
Average
Remaining
Contractual Life
    Number of
Shares
    Weighted
Average
Remaining
Contractual Life
 
$ 0.00 - $ 1.00       459,080       4.51       456,179       4.49  
$ 1.01 - $ 2.00       130,510       9.91       4,909       9.91  
$ 2.01 - $ 3.00       459,786       9.65       41,850       9.09  
$ 3.01 - $ 4.00       110,530       9.19       48,066       9.19  
$ 5.01 - $ 6.00       66,924       8.75       54,530       8.75  
$ 6.01 - $ 7.00       170,069       8.75       56,689       8.75  
$ 8.01 - $ 9.00       2,353       8.86       686       8.86  
Total       1,399,252       7.79       662,909       5.87  
Schedule of Estimate Fair Value of Stock Options

For the years ended December 31, 2022, and 2021, the Company utilized the Black-Scholes option-pricing model for estimating the fair value of the stock option granted. The Company estimated the fair value of each option grant on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:

 

    Years Ended December 31, 
   2022    2021 
Expected volatility   100.48% – 103.20 %   41.66% – 82.12 %
Expected term (years)   5.2710.00    5.006.33 
Risk-free interest rate   1.93% – 4.05 %   0.62% – 1.36 %
Dividend rate   %   %
Schedule of Stock Based Compensation Expense

The following table summarizes the components of stock-based compensation expense recognized in the Company’s statements of operations and comprehensive loss during the years ended December 31, 2022, and 2021 (in thousands):

 

   2022   2021 
   Years Ended December 31, 
   2022   2021 
Research and development  $134   $26 
General and administrative   510    121 
Total stock-based compensation expense  $644   $147 
Schedule of Warrant Activity

The following is a summary of the common stock warrant activity during the year ended December 31, 2022:

 

   Shares Issuable Upon Exercise of Outstanding Warrants  

Weighted-

Average Exercise

Price

   Weighted- Average Remaining Contractual Life (in years)  

Aggregate

Intrinsic Value

(in thousands)

 
Outstanding as of December 31, 2021   2,786,995   $10.80    4.67   $30,100 
Issued   -    -    -    - 
Exercised   -    -    -    - 
Expired   -    -    -    - 
Outstanding as of December 31, 2022   2,786,995   $10.80    3.67   $30,100